Adverse Events from Emollient Use in Eczema: A Restricted Review of Published Data

Abstract

Atopic dermatitis/eczema is a chronic inflammatory skin condition, and emollients are the first-line treatment. Despite their widespread use, there is uncertainty about the frequency and type of adverse events associated with different emollients. We conducted a restricted review of published data on adverse events associated with emollient use in eczema. Medline (Ovid) was searched from inception (1946) to June 2018. All types of studies, with the exception of reviews, were included. Eligibility was assessed using a two-stage screening process against inclusion and exclusion criteria. References of all included papers were screened for any additional eligible papers. Data were subsequently extracted from all eligible publications. A limited body of data were found in the published data: 24 papers reported on adverse events with 29 different emollients (3 containing urea, 5 containing ceramide, 4 containing glycerol, 4 were herbal and 13 contained “other” ingredients). Interpretation of the results and comparison of the emollients were difficult due to poor reporting and missing data. Many publications contained no data at all on adverse events, and no study reported serious treatment-related adverse events for any emollient. The proportion of participants in the studies experiencing treatment-related adverse events varied between 2 and 59%. The most common adverse events were skin related and often mild. The range of participants experiencing non-treatment-related adverse events varied between 4 and 43%. From this restricted review, clinicians and patients can be reassured that the emollients studied appear to be generally safe to use. Better studies and reporting of adverse events associated with emollients in common use are needed. Electronic supplementary material The online version of this article (10.1007/s13555-019-0284-3) contains supplementary material, which is available to authorized users.

Burns with emollients

“…Transient application site reactions such as stinging or redness are common occurring in around one third of users. 5 While, generally, most emollients will lose moisture ("dry"), most (but not all) ointments that are nearly 100% paraffin base will not do so. Tests with wet emollients have resulted in longer time to ignition compared to just the fabric itself.…”

What’s new in atopic eczema? An analysis of systematic reviews published in 2019. Part 2: treatment

“…One SR 7 examined adverse events associated with the use of emollients in AE across 17 RCTs, five nonrandomized studies on interventions (NRSIs), one cohort and one case–control study (in total, 1887 participants). The emollients examined appeared to be safe to use but the authors recognized poor and incomplete reporting across the available studies, and acknowledged the need for further and better‐designed studies before any conclusive recommendations can be made.…”

Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence

“…Moisturizers come in many formulations, ranging from oils and ointments to lotions and gels. Moisturizers are not created with equal component ingredients; some can actually worsen skin function and even induce skin irritation [48,49]. Traditionally, ointments and occlusives were thought to be the most beneficial for eczema because of their protective effects, whereas creams were assumed to provide better moisturization than lotions because of their greater viscosity.…”